1439 - Intravesical instillation of sodium hyaluronate (1.6%) & sodium chondroitin sulphate (2.0%) for Painful Bladder Syndrome / Interstitial Cystitis, Recurrent Urinary Tract Infection and Radiation Induced Cystitis

Page last updated: 10 October 2016

Application Detail

Status

Open

Description of Medical Service

iAluRil is instilled into the bladder and held for as long as possible (30 + mins).

Description of Medical Condition

iAluRil therapy is indicated to re-establish the glycosaminoglycan layers (GAGs) of the urothelial vesical tissue in cases in which their loss can cause frequent and recurring problems such as Painful Bladder Syndrome (PBS), interstitial cystitis (IC), treatment and prevention of recurrent urinary tract infection, cystitis as a result of Bacillus Calmette Guerin therapy, or chemical and radiation therapy.
iAluRil therapy is also indicated in the cases where the loss of the glycosaminoglycan layers (GAGs) is associated with forms of chronic inflammation, in which their composition and integrity appears compromised in different ways.

Reason for Application

New MBS item

Medical Service Type

Therapeutic

Previous Application Number

Not Applicable

Associated Documentation

Application Form

-

PICO Confirmation

Consultation Protocol (PDF 1606 KB)
Consultation Protocol (Word 1069 KB)

Assessment Report

-

Public Summary Document

-

Meetings for this Application

PASC

11 - 12 August 2016

ESC

-

MSAC

-